|
|
Other links at Articles > Cardiology |
| 2. |
MEND-CABG II: No Benefit of MC-1 in Reducing Death/MI Post-CABG
|
|
|
The lead investigator says the drug, based on a metabolite of vitamin B6, likely has no future as a cardioprotective agent in bypass surgery but may yet prove to have other beneficial metabolic properties, provided its developer has deep enough pockets to continue to study it. Heartwire
|
| 4. |
ACC 2008: The Future of Managing Dyslipidemia
|
|
|
ACC.08: Statins may be wonder drugs, but they still leave a significant percentage of patients at risk -- so the latest clinical trial and research results will be good news for treating dyslipidemia. Medscape Cardiology
|
|
|